Masanori Kotake

Kouseiren Takaoka Hospital

Papers

4

Total Citations

39

H-Index

2

About

Dr. Masanori Kotake is a leading colorectal surgeon whose research focuses on advancing minimally invasive surgical techniques for locally advanced rectal cancer, particularly through laparoscopic and robotic-assisted approaches. He has made pivotal contributions to establishing quality standards in rectal cancer surgery, most notably as the principal investigator of the PRODUCT trial, a landmark Japanese multicenter prospective study that validated laparoscopic surgery for locally advanced rectal cancer using circumferential resection margin (CRM) and total mesorectal excision (TME) quality as universal indices. This work, cited 19 times, has helped standardize surgical evaluation in Japan. Dr. Kotake also led the VITRUVIANO trial, a multicentre prospective phase II study demonstrating the feasibility of robotic-assisted surgery in advanced rectal cancer, with 17 citations. His clinical expertise extends to managing complex anatomical variations, as shown in his report on robot-assisted anterior resection for rectal cancer with double inferior vena cava, and to performing innovative simultaneous robotic resections for giant uterine fibroids and rectal cancer. Through these high-impact studies, Dr. Kotake is shaping the future of precision surgery in colorectal oncology.

Research Focus

Key Achievements

2
H-Index
4
Papers
39
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Japanese multicenter prospective study investigating laparoscopic surgery for locally advanced rectal cancer with evaluation of CRM and TME quality (PRODUCT trial)
19 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 49
🏛 Institutions: Kouseiren Takaoka Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago